Institutional Ownership Phathom Pharmaceuticals, Inc. (PHAT)
This table provides information about the institutional ownership of Phathom Pharmaceuticals, Inc. (PHAT). We have compiled data on the 138 institutions that hold shares in the stock, with a total of 60.5 Million shares, which have been reported (via 13F filing form) to have a value of $628 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
419,473
shares
|
$4.35 Million
0.0% of portfolio
|
Q2 2025
Reduced 40.72%
|
|
Ghost Tree Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
375,000
shares
|
$3.89 Million
2.54% of portfolio
|
Q3 2024
Reduced 37.5%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
360,160
shares
|
$3.74 Million
0.0% of portfolio
|
Q2 2025
Added 3.48%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
359,324
shares
|
$3.73 Million
0.0% of portfolio
|
Q2 2025
Reduced 7.06%
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
306,399
shares
|
$3.18 Million
0.02% of portfolio
|
Q2 2025
New holding
|
|
Susquehanna Portfolio Strategies, LLC
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
267,962
shares
|
$2.78 Million
0.06% of portfolio
|
Q2 2025
New holding
|
|
Rothschild & CO Asset Management Us Inc.
New York, NY |
Feb 14, 2023 Q4 2022 |
245,658
shares
|
$2.55 Million
0.04% of portfolio
|
Q4 2022
Added 18.43%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
192,526
shares
|
$2 Million
0.0% of portfolio
|
Q2 2025
Added 2.48%
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
187,291
shares
|
$1.94 Million
0.01% of portfolio
|
Q2 2025
Reduced 75.08%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Aug 14, 2025 Q2 2025 |
180,851
shares
|
$1.88 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
157,941
shares
|
$1.64 Million
0.0% of portfolio
|
Q2 2025
Added 1451.18%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
154,928
shares
|
$1.61 Million
0.0% of portfolio
|
Q2 2025
Reduced 86.3%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
147,523
shares
|
$1.53 Million
0.0% of portfolio
|
Q4 2024
Reduced 4.44%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
137,393
shares
|
$1.43 Million
0.0% of portfolio
|
Q1 2025
Added 0.35%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
134,208
shares
|
$1.39 Million
0.0% of portfolio
|
Q2 2025
Reduced 16.71%
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
110,110
shares
|
$1.14 Million
0.0% of portfolio
|
Q2 2025
Added 8.46%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
96,080
shares
|
$997,310
0.0% of portfolio
|
Q2 2025
Reduced 43.58%
|
|
State Of Wisconsin Investment Board
Madison, WI |
Aug 14, 2025 Q2 2025 |
90,781
shares
|
$942,306
0.0% of portfolio
|
Q2 2025
Reduced 9.02%
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
82,170
shares
|
$852,924
0.0% of portfolio
|
Q2 2025
Added 49.67%
|
|
Swiss National Bank
Zurich, V8 |
May 12, 2025 Q1 2025 |
73,300
shares
|
$760,854
0.0% of portfolio
|
Q3 2024
Added 30.89%
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
64,557
shares
|
$670,101
0.0% of portfolio
|
Q2 2025
Added 13.78%
|
|
Adar1 Capital Management, LLC
Austin, TX |
Aug 14, 2025 Q2 2025 |
63,424
shares
|
$658,341
0.09% of portfolio
|
Q2 2025
Added 48.19%
|
|
Penn Mutual Asset Management, LLC
Horsham, PA |
Aug 14, 2025 Q2 2025 |
62,802
shares
|
$651,884
1.85% of portfolio
|
Q4 2022
Reduced 27.76%
|
|
Creative Planning
Overland Park, KS |
Aug 08, 2025 Q2 2025 |
57,264
shares
|
$594,400
0.0% of portfolio
|
Q2 2025
Reduced 4.46%
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
50,590
shares
|
$525,124
0.0% of portfolio
|
Q2 2025
Added 10.97%
|